Metoprolol Succinate
Product Images NDC 50816-050

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 50816-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by New American Therapeutics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image01

This is a description of a medication called Metoprolol Succinate. The medication comes in the form of extended-release tablets, and the text on the package indicates that each bottle contains 100 tablets, each with a strength of 25mg. The medication is only available to individuals with a prescription. The text also includes various identification numbers, including 92052091805500 NI19 and NDC50816-025-02, as well as manufacturing information such as Rev 072020.*

FDA Label Image

Image02

Metoprolol Succinate Extended-release Tablets are available in a bulk package of 1000 tablets, each containing 25mg of the active ingredient. The tablets are distributed by AstraZeneca AB in Sweden and are not intended for dispensing to patients directly.*

FDA Label Image

Image03

This is a medicine package of Metoprolol Succinate Extended-Release Tablets containing 100 tablets manufactured in Sweden. The NDC number of the package is 50816-050-02. The package revision date is July 2020. The rest of the text is unclear and cannot be deciphered.*

FDA Label Image

Image04

This is a package with 1000 Metoprolol Succinate extended-release tablets of 50mg each, manufactured by AstraZeneca AB in Sweden and distributed by New American Therapeutics in NJ, USA. The package is not intended for dispensing and is for prescription-only use.*

FDA Label Image

Image05

This is a description of a medication called Metoprolol Succinate Extended-release Tablets. The medication is manufactured by AstraZeneca, and the package contains 100 tablets, each containing 100 mg of oprolo succinate. It is a prescription drug and comes with an NDC code: 5081610002. Additional information includes Lot number- B R 072020, and manufacturing location SECTT 85 Saderie, oo Traapaics.*

FDA Label Image

Image06

This description is not available. The text appears to be a mix of numbers, codes and letters that do not form a cohesive message.*

FDA Label Image

Image07

This is a description of a medication with the NDC code 38094-50. The medication is identified as Metoprolol Succinate and comes in an extended-release tablet form with a potency of 200mg. The medication comes in a bottle of 100 tablets and is only available with a prescription (Rx only). The other text appears to be random characters and numbers that are not useful in generating a description.*

FDA Label Image

Image08

This is a bulk package of 1000 extended-release tablets of Metoprolol Succinate, with a strength of 200 mg each. The package is not intended for dispensing.*

FDA Label Image

Image09

FDA Label Image

Image10

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.